Type I Insulin-like Growth Factor Receptors in Human Colorectal Cancer

By Adenis A.   Peyrat J.-P.   Hecquet B.   Delobelle A.   Depadt G.   Quandalle P.   Bonneterre J.   Demaille A.  

European Journal of Cancer, Vol. 31, Iss. 1, 1995-01 ,pp. : 50-55

Elsevier

Access to resources Recommend Favorite

Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody

By                        

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1453-1460

Spandidos Publications

Access to resources Recommend Favorite

Targeting of Insulin-like Growth Factor-I Receptor with a Monoclonal Antibody Inhibits Growth of Hepatic Metastases from Human Colon Carcinoma in Mice

By Bauer Todd  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2838-2846

Springer Publishing Company

Access to resources Recommend Favorite

In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer

By            

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 87-94

Spandidos Publications

Access to resources Recommend Favorite

Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells

By Dong Zhizhen   Yao Min   Wang Li   Yan Xiaodi   Gu Xing   Shi Yun   Yao Ninghua   Qiu Liwei   Wu Wei   Yao Dengfu  

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 3397-3405

Springer Publishing Company

Access to resources Recommend Favorite